Literature DB >> 16998703

Changes in expression of genes related to cell proliferation in human mesenchymal stem cells during in vitro culture in comparison with cancer cells.

Rumi Sawada1, Tomomi Ito, Toshie Tsuchiya.   

Abstract

We investigated the expression levels of several genes related to cell proliferation in human mesenchymal stem cells (hMSCs) during in vitro culture for use in clinical applications. In this study, we focused on the relationship between hMSC proliferation and transforming growth factor beta (TGFbeta) signaling during in vitro culture. The proliferation rate of hMSCs gradually decreased and marked changes in hMSC morphology were not observed in 3 months of in vitro culture. The mRNA expressions of TGFbeta1, TGFbeta2, and TGFbeta receptor type I (TGFbetaRI) in hMSCs increased with the length of cell culture. There had been no change in the TGFbeta3, TGFbetaRII, and TGFbetaRIII mRNA expressions by the 12th passage from the primary culture (at about 3 months). The mRNA expression of Smad3 increased, but those of c-myc and nucleostemin decreased with the length of hMSC in vitro culture. In addition, the expression profiles of the genes that regulate cellular proliferation in hMSCs were significantly different from those of cancer cells. In conclusion, hMSCs derived from bone marrow seldom underwent spontaneous transformation during 1-2 months of in vitro culture for use in clinical applications. In hMSCs as well as in epithelial cells, growth might be controlled by the TGFbeta family signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998703     DOI: 10.1007/s10047-006-0338-z

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  23 in total

1.  A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells.

Authors:  Robert Y L Tsai; Ronald D G McKay
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

2.  Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A.

Authors:  J Esparza-Lopez; J L Montiel; M M Vilchis-Landeros; T Okadome; K Miyazono; F López-Casillas
Journal:  J Biol Chem       Date:  2001-02-05       Impact factor: 5.157

3.  Pluripotency of mesenchymal stem cells derived from adult marrow.

Authors:  Yuehua Jiang; Balkrishna N Jahagirdar; R Lee Reinhardt; Robert E Schwartz; C Dirk Keene; Xilma R Ortiz-Gonzalez; Morayma Reyes; Todd Lenvik; Troy Lund; Mark Blackstad; Jingbo Du; Sara Aldrich; Aaron Lisberg; Walter C Low; David A Largaespada; Catherine M Verfaillie
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

Review 4.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

Review 5.  Prometheus's vulture and the stem-cell promise.

Authors:  Nadia Rosenthal
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

6.  Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling.

Authors:  G C Blobe; W P Schiemann; M C Pepin; M Beauchemin; A Moustakas; H F Lodish; M D O'Connor-McCourt
Journal:  J Biol Chem       Date:  2001-04-25       Impact factor: 5.157

7.  Spontaneous human adult stem cell transformation.

Authors:  Daniel Rubio; Javier Garcia-Castro; María C Martín; Ricardo de la Fuente; Juan C Cigudosa; Alison C Lloyd; Antonio Bernad
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

8.  Wnt proteins are lipid-modified and can act as stem cell growth factors.

Authors:  Karl Willert; Jeffrey D Brown; Esther Danenberg; Andrew W Duncan; Irving L Weissman; Tannishtha Reya; John R Yates; Roel Nusse
Journal:  Nature       Date:  2003-04-27       Impact factor: 49.962

9.  Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.

Authors:  X Deng; S Bellis; Z Yan; E Friedman
Journal:  Cell Growth Differ       Date:  1999-01

10.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone.

Authors:  Edwin M Horwitz; Patricia L Gordon; Winston K K Koo; Jeffrey C Marx; Michael D Neel; Rene Y McNall; Linda Muul; Ted Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

View more
  16 in total

1.  Journal of Artificial Organs 2006: the year in review.

Authors:  Y Sawa; T Horiuchi; A Kishida; T Masuzawa; M Nishimura; E Tatsumi; Y Tomizawa; H Watanabe
Journal:  J Artif Organs       Date:  2007-06-20       Impact factor: 1.731

2.  SIRT1 is required for long-term growth of human mesenchymal stem cells.

Authors:  Hong-Feng Yuan; Chao Zhai; Xin-Long Yan; Dan-Dan Zhao; Jing-Xue Wang; Quan Zeng; Lin Chen; Xue Nan; Li-Juan He; Si-Ting Li; Wen Yue; Xue-Tao Pei
Journal:  J Mol Med (Berl)       Date:  2011-10-27       Impact factor: 4.599

Review 3.  Stem cells and regenerative medicine: accomplishments to date and future promise.

Authors:  Karim Y Helmy; Shyam A Patel; Kimberly Silverio; Lillian Pliner; Pranela Rameshwar
Journal:  Ther Deliv       Date:  2010-11

4.  Continual expression throughout the cell cycle and downregulation upon adipogenic differentiation makes nucleostemin a vital human MSC proliferation marker.

Authors:  Pinar Akpinar Oktar; Sibel Yildirim; Deniz Balci; Alp Can
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

5.  Functional response to SDF1 alpha through over-expression of CXCR4 on adult subventricular zone progenitor cells.

Authors:  Xian Shuang Liu; Michael Chopp; Manoranjan Santra; Ann Hozeska-Solgot; Rui Lan Zhang; Lei Wang; Hua Teng; Mei Lu; Zheng Gang Zhang
Journal:  Brain Res       Date:  2008-06-14       Impact factor: 3.252

6.  FGF-2 increases osteogenic and chondrogenic differentiation potentials of human mesenchymal stem cells by inactivation of TGF-beta signaling.

Authors:  Tomomi Ito; Rumi Sawada; Yoko Fujiwara; Toshie Tsuchiya
Journal:  Cytotechnology       Date:  2007-10-18       Impact factor: 2.058

7.  Human umbilical cord matrix stem cells maintain multilineage differentiation abilities and do not transform during long-term culture.

Authors:  Isabelle Scheers; Catherine Lombard; Massimiliano Paganelli; David Campard; Mustapha Najimi; Jean-Luc Gala; Anabelle Decottignies; Etienne Sokal
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

8.  Anti-senescence efficacy of radio-electric asymmetric conveyer technology.

Authors:  Margherita Maioli; Salvatore Rinaldi; Sara Santaniello; Alessandro Castagna; Gianfranco Pigliaru; Alessandro Delitala; Matteo Lotti Margotti; Luigi Bagella; Vania Fontani; Carlo Ventura
Journal:  Age (Dordr)       Date:  2013-05-09

Review 9.  Toward personalized cell therapies by using stem cells: seven relevant topics for safety and success in stem cell therapy.

Authors:  Fernando de Sá Silva; Paula Nascimento Almeida; João Vitor Paes Rettore; Claudinéia Pereira Maranduba; Camila Maurmann de Souza; Gustavo Torres de Souza; Rafaella de Souza Salomão Zanette; Sueli Patricia Harumi Miyagi; Marcelo de Oliveira Santos; Márcia Martins Marques; Carlos Magno da Costa Maranduba
Journal:  J Biomed Biotechnol       Date:  2012-11-20

Review 10.  Strategies to improve the immunosuppressive properties of human mesenchymal stem cells.

Authors:  Myoung Woo Lee; Somi Ryu; Dae Seong Kim; Ki Woong Sung; Hong Hoe Koo; Keon Hee Yoo
Journal:  Stem Cell Res Ther       Date:  2015-10-07       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.